Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

JFL Capital Management, LLC Create: Alert

All | News | Filings
Date FiledTypeDescription
11/19/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
09/24/2019 SC 13D/A JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc.
09/24/2019 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
08/22/2019 DFAN14A Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
08/19/2019 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
08/13/2019 PRRN14A Form PRRN14A - Non-management revised preliminary proxy soliciting materials, contested and otherwise:
08/06/2019 PREC14A Form PREC14A - Preliminary proxy statements, contested solicitations:
07/24/2019 SC 13D/A JFL Capital Management, LLC reports a 9.4% stake in Merrimack Pharmaceuticals, Inc.
07/02/2019 4 JFL Capital Management, LLC (10% Owner) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 9,662 shares @ $5.945, valued at $57.4k
Bought 13,902 shares @ $5.945, valued at $82.6k
Bought 3,934 shares @ $6.0029, valued at $23.6k
Bought 5,659 shares @ $6.0029, valued at $34k
Bought 7,024 shares @ $5.848, valued at $41.1k
Bought 10,107 shares @ $5.848, valued at $59.1k
05/31/2019 SC 13G JFL Capital Management, LLC reports a 6% stake in Novelion Therapeutics Inc.
04/17/2019 SC 13D/A JFL Capital Management, LLC reports a 9.3% stake in Merrimack Pharmaceuticals, Inc.
04/09/2019 4 JFL Capital Management, LLC (10% Owner) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns: Bought 26,288 shares @ $5.952, valued at $156.5k
Bought 6,484 shares @ $5.7264, valued at $37.1k
Bought 4,506 shares @ $5.7264, valued at $25.8k
03/20/2019 3 JFL Capital Management, LLC (10% Owner) has filed a Form 3 on MERRIMACK PHARMACEUTICALS INC
03/14/2019 SC 13D/A JFL Capital Management, LLC reports a 8.7% stake in Merrimack Pharmaceuticals, Inc.
02/11/2019 SC 13G/A JFL Capital Management, LLC reports a 7% stake in Catalyst Biosciences, Inc.
01/25/2019 SC 13G JFL Capital Management, LLC reports a 8.2% stake in Sunesis Pharmaceuticals, Inc.
12/19/2018 SC 13D/A JFL Capital Management, LLC reports a 8.5% stake in Merrimack Pharmaceuticals, Inc.
11/02/2018 SC 13D JFL Capital Management, LLC reports a 7.1% stake in Merrimack Pharmaceuticals, Inc.
08/02/2018 SC 13G JFL Capital Management, LLC reports a 5.4% stake in Catalyst Biosciences, Inc.
07/27/2018 3/A JFL Capital Management, LLC (5% owner) has filed a Form 3/A on CATALYST BIOSCIENCES, INC.
07/27/2018 3 JFL Capital Management, LLC (5% owner) has filed a Form 3 on CATALYST BIOSCIENCES, INC.
10/19/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy